Concepedia

Emi Ishikawa

EI

Statistics

Publications

3

Citations

42

H-Index

3

Active since

2022

Affiliations

Keio University(Current)

Keio University Hospital

Hakodate Central General Hospital

Emi Ishikawa is an author at Keio University specializing in bioanalysis, pre-clinical pharmacology, and drug discovery.

ORCID

Top concepts

Publications per year

2022–2023

3

Publications

3

Population Pharmacokinetics, Pharmacogenomics, and Adverse Events of Osimertinib and its Two Active Metabolites, AZ5104 and AZ7550, in Japanese Patients with Advanced Non-small Cell Lung Cancer: a Prospective Observational Study

Emi Ishikawa, Yuta Yokoyama, Haruna Chishima et al. · Investigational New Drugs · 2023 · 20 citations · Full text

Development and validation of a new liquid chromatography-tandem mass spectrometry assay for the simultaneous quantification of afatinib, dacomitinib, osimertinib, and the active metabolites of osimertinib in human serum

Emi Ishikawa, Yuta Yokoyama, Haruna Chishima et al. · Journal of Chromatography B · 2022 · 11 citations · Full text

, , +26

Simultaneous quantification of dasatinib, nilotinib, bosutinib, and ponatinib using high‐performance liquid chromatography–Photodiode array detection

Yuta Yokoyama, Eiji Nozawa, Miho Morita et al. · Journal of Clinical Laboratory Analysis · 2022 · 11 citations · Full text

1–3 of 3